期刊文献+

子宫内膜癌46例临床诊治分析 被引量:2

下载PDF
导出
摘要 子宫内膜癌是发生于子宫内膜的一组上皮恶性肿瘤,其中以源于子宫内膜腺体的腺癌最常见;是女性生殖道三大恶病理类型性肿瘤之一,占女性全身恶性肿瘤的7%,占女性生殖道恶性肿瘤的20%一30%.其发病率呈逐渐上升趋势,多见于绝经后妇女,你年轻妇女亦不少见。病因尚不清楚,发病类型有雌激素依赖型和非雌激素依赖型两种;前者的患者常年轻,伴有高血压、糖尿病、肥胖以及不孕等,肿瘤分化较好,预后好;后者多见于老年体瘦妇女,肿瘤分化差,预后不良。病理类型可分为内膜样腺癌、腺癌伴鳞状上皮化生、浆液性腺癌及透明细胞癌四种,其中以内膜样腺癌最多见,占80%—90%。目的:探讨子宫内膜癌的临床诊断、治疗手段以及疗效,总结早期诊断经验及提高治疗水平。方法:将2007年6月-2008年6月我院收入的46例子宫内膜癌患者根据病情制定合理正确的治疗方案,治疗后随访3年,记录临床资料并作回顾性分析。结果:10例在第1年内复发;12例在第2年复发;3例第3年复发;21例随访结束时仍正常。结论:随访发现子宫内膜癌的预后受多种因素影响,经过积极合理正确的临床治疗,能够提高延长患者的生命。
作者 陈建云
出处 《中国中医药咨讯》 2012年第3期147-147,共1页
  • 相关文献

参考文献1

二级参考文献18

  • 1Keys HM, Roberts JA, Brunetto VL, et al. A phase Ⅲ trial of surgery with or without adjuvant external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a GOG study [J]. Gynecol Oncol, 2004, 92(4): 744-751
  • 2Solhjem MG, Petersen IA, Haddock MG. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer[J]. Int J Radiat Oncol Biol Phys, 2005, 62(5): 1379-1384
  • 3Gengiz M, Singh AK, Grigsby PW. Postoperative vaginal brachytherapy alone is the treatment of choice for grade 1-2,stage I G endometrial cancer [J]. Int J Gynecol Cancer, 2005, 15(5): 926 -931
  • 4von Minckwitz G, Loibl S, Brunnert K, et al. Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage Ⅰ and Ⅱ endometrial cancer-a multicenter, open, controlled,prospectively randomized trial[J].Eur J Gancer, 2002, 38 (17):2265 -2271
  • 5Mariani A, Keeney GL, Aletti G, et al. Endometrial carcinoma: paraaortic dissemination[J]. Gynecol Oncol, 2004, 92(3): 833-838
  • 6Sutton G, Axelrod JH, Bundy BN, et al. Whole abdomlnal radiotherapy in the adjuvant treatment of patients with stage Ⅲ and Ⅳ endometrial cancer: a COG study[J]. Gynecol Oncol, 2005, 97(3):755 - 763
  • 7Bruzzone M, Miglietta L, Franzone P, et al. Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage Ⅲ-Ⅳ endometrial cancer patients [J]. Gynecol Oncol, 2004, 93 (2):345-352
  • 8Greven K, Winter K, Underhili K, et al. Preliminary analysis of RTOG 9708:adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer [J]. Int J Radiat Oncol Biol Phys,2004, 59(1): 168-173
  • 9Duska LR, Berkowitz R, Matulonis U, et al. A pilot trial of TAG(paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim support followed by radiotherapy in patients with highrisk endometrial cancer[J]. Gynecol Oncol, 2005, 96(1): 198-203
  • 10Soper ,JT, Reisinger SA, Ashbury R, et al. Feasibility study of concurrent weeldy.cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advancedstage endometrial carcinoma: a GOG study [J]. Gyencol Oncol,2004, 95(1): 95-100

共引文献5

同被引文献4

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部